The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease
Abstract
Salvia lavandulaefolia Vahl. (Spanish sage) essential oil and individual monoterpenoid constituents have been shown to inhibit the enzyme acetylcholinesterase in-vitro and in-vivo. This activity is relevant to the treatment of Alzheimer's disease, since anticholinesterase drugs are currently the only drugs available to treat Alzheimer's disease. Other activities relevant to Alzheimer's disease include antioxidant, anti-inflammatory and estrogenic effects. Results of in-vitro tests for these activities are reported here for S. lavandulaefolia extracts, the essential oil and its major constituents. Antioxidant activity (inhibition of bovine brain liposome peroxidation) was found in the EtOH extract of the dried herb (5 mg mL−1) and the monoterpenoids (0.1 M) α- and β-pinene and 1,8-cineole. Thujone and geraniol had lower antioxidant effects, while camphor had no antioxidant effects. Possible anti-inflammatory activity (eicosanoid inhibition in rat leucocytes) was found in the EtOH extract (50 μg mL−1) and was shown by the monoterpenoids α-pinene and geraniol (0.2 mM), but not 1,8-cineole, thujone or camphor. Possible estrogenic activity (via induction of β-galactosidase activity in yeast cells) was found in the essential oil (0.01 mg mL−1) and the monoterpenoid geraniol (0.1–2 mM). 1,8-Cineole, α- and β-pinene and thujone did not exhibit estrogenic activity in this analysis. These results demonstrate that S. lavandulaefolia, its essential oil and some chemical constituents have properties relevant to the treatment of Alzheimer's disease and provide further data supporting the value of carrying out clinical studies in patients with Alzheimer's disease using this plant species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Different Mechanisms of Oxidative Stress and Neurotoxicity for Alzheimer‘s Aβ(1−42) and Aβ(25−35)
Varadarajan, S., Kanski, J., Aksenova, M., Lauderback, C., & Butterfield, D. A. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010452r · Cited by 346
Research works printed but not linked: 45
- Abelson, 1994, Methods in Enzymology, Vol 234, 443, 10.1016/0076-6879(94)34115-X · DOI
- Adam, 1998, Antifungal activities of Origanum vulgare subsp. hirtum, Mentha spicata, Lavandula augustifolia, and Salvia fruticosa essential oils against human pathogenic fungi, J. Agric. Food Chem., 46, 1739, 10.1021/jf9708296 · DOI · Paper page
- Aisen, 1996, Inflammation and Alzheimer's disease, Mol. Chem. Neuropathol., 28, 83, 10.1007/BF02815208 · DOI
- Aruoma, 1996, Assessment of potential prooxidant and anti-oxidant actions, JAOCS, 73, 1617, 10.1007/BF02517962 · DOI
- Aruoma, 1996, An evaluation of the antioxidant and antiviral action of the extracts of rosemary and provencal herbs, Food Chem. Toxicol., 34, 449, 10.1016/0278-6915(96)00004-X · DOI · Paper page
- Bartram, 1995, Encyclopaedia of Herbal Medicine, 379
- Behl, 1997, Neuroprotection against oxidative stress by estrogens: structure-activity relationship, Am. Soc. Pharmacol. Exp. Ther., 51, 535
- Bingol, 1995, A review of terrestrial plants and marine organisms having antiinflammatory activity, Int. J. Pharmacog., 33, 81, 10.3109/13880209509055206 · doi:10.3109/13880209509055206
- BirkHäuser, 2000, Oestrogens and Alzheimer's disease, Int. J. Geriatr. Psychiatry, 15, 600, 10.1002/1099-1166(200007)15:7<600::AID-GPS155>3.0.CO;2-7 · DOI
- Bouchet, 1998, Radical scavenging activity and antioxidant properties of tannins from Guiera senegalensis (Combretaceae), Phytother. Res., 12, 159, 10.1002/(SICI)1099-1573(199805)12:3<159::AID-PTR209>3.0.CO;2-C · DOI
- Brautigam, 1998, Treatment of age-related memory complaints with Ginkgo biloba extract: a randomised double blind placebo-controlled study, Phytomedicine, 5, 425, 10.1016/S0944-7113(98)80038-X · DOI
- Breitner, 1996, Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal, Neurobiol. Aging, 17, 789, 10.1016/0197-4580(96)00109-1 · DOI · Paper page
- Carr, 1997, Current concepts in the pathogenesis of Alzheimer's disease, Am. J. Med., 103, 3S, 10.1016/S0002-9343(97)00262-3 · DOI
- Cooper, 2000, Key issues in Alzheimer's disease inflammation, Neurobiol. Aging, 21, 451, 10.1016/S0197-4580(00)00148-2 · DOI
- Culvelier, 1996, Antioxidant activity and phenolic composition of pilot-plant and commercial extracts of sage and rosemary, JAOCS, 73, 645, 10.1007/BF02518121 · DOI · Paper page
- De Vries, 1997, The blood-brain barrier in neuroinflammatory diseases, Pharmacol. Rev., 49, 143
- Dorman, 1995, Evaluation in vitro of plant essential oils as natural antioxidants, J. Essent. Oil. Res., 7, 645, 10.1080/10412905.1995.9700520 · DOI · Paper page
- Frölich, 1995, Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidant treatment, Drug Res., 45, 443
- Gambassi, 1996, Oestrogen and Alzheimer's disease, Lancet, 348, 1027, 10.1016/S0140-6736(05)64952-5 · doi:10.1016/s0140-6736(05)64952-5
- Graven, 1992, Antimicrobial and antioxidative properties of the volatile (essential oil) of Artemisia afra Jacq, Flav. Frag. J., 7, 121, 10.1002/ffj.2730070305 · doi:10.1002/ffj.2730070305
- Green, 1998, Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione, Neuroscience, 84, 7, 10.1016/S0306-4522(97)00595-2 · DOI · Paper page
- Halliwell, 1995, Antioxidant characterization: methodology and mechanism, Biochem. Pharmacol., 49, 1341, 10.1016/0006-2952(95)00088-H · DOI · Paper page
- Harborne, 1991, Ecological Chemistry and Biochemistry of Plants Terpenoids
- Hernandez-Perez, 1995, Analgesic, antiinflammatory, antipyretic and hematological effects of aethiopinene, an omicron-naphthoquinone diterpenoid from Salvia aethiopis roots and two hemisynthetic derivatives, Planta Med., 61, 505, 10.1055/s-2006-959358 · doi:10.1055/s-2006-959358
- Huang, 1996, Antioxidant activity of carnosic acid and methyl carnosate in bulk oils and oil-in-water emulsions, J. Agric. Food Chem., 44, 2951, 10.1021/jf960068r · DOI
- Jiménez, 1995, Effects of Salvia lavandulifolia Vahl. ssp. Oxyodon extract on pancreatic endocrine tissue in steptozotocin-diabetic rates, Phytother. Res., 9, 536, 10.1002/ptr.2650090717 · doi:10.1002/ptr.2650090717
- Jordan, 1998, Designer estrogens, Sci. Am., 279, 60, 10.1038/scientificamerican1098-60 · doi:10.1038/scientificamerican1098-60
- Kang, 1997, Antioxidant effects of Salvia miltiorrhiza, Arch. Pharmacol. Res., 20, 496, 10.1007/BF02973947 · DOI
- Kanowski, 1997, Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia, Phytomedicine, 4, 3, 10.1016/S0944-7113(97)80021-9 · DOI
- Le Bars, 1997, A placebo-controlled, double blind, randomized trial of an extract of Ginkgo biloba for dementia, JAMA, 278, 1327, 10.1001/jama.1997.03550160047037 · DOI · Paper page
- Littlefield, 1990, A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in ishikawa cells: estrogenic action of delta 5 adrenal steroids, Endocrinology, 127, 2757, 10.1210/endo-127-6-2757 · DOI · Paper page
- Masaki, 1995, Active-oxygen scavenging activity of plant extracts, Biol. Pharm. Bull., 18, 162, 10.1248/bpb.18.162 · DOI · Paper page
- Moroney, 1988, Selectivity of neutrophil 5-lipoxygenase and cyclooxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids, J. Pharm. Pharmacol., 40, 787, 10.1111/j.2042-7158.1988.tb05173.x · DOI · Paper page
- Mulnard, 2000, Estrogen replacement therapy for treatment of mild to moderate Alzheimers disease — A randomised controlled trial, J. Am. Med. Ass., 283, 1007, 10.1001/jama.283.8.1007 · DOI · Paper page
- Murray, 1998, Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyrus, J. Biol. Chem., 273, 12 161, 10.1074/jbc.273.20.12161 · DOI
- Pratico, 2000, Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease, Am. J. Med., 109, 577, 10.1016/S0002-9343(00)00547-7 · DOI · Paper page
- Rogers, 1995, Inflammation as a pathogenic mechanism in Alzheimer's disease, Drug Res., 45, 439
- Routledge, 1996, Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen, Environ. Toxicol. Chem., 15, 241, 10.1002/etc.5620150303 · DOI · Paper page
- Santos, 1997, Mast cell involvement in the rat paw oedema response to 1,8-cineole, the main constituent of eucalyptus and rosemary oils, Eur. J. Pharmacol., 331, 253, 10.1016/S0014-2999(97)01013-3 · DOI
- Simpkins, 1997, Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease, Am. J. Med., 103, 19S, 10.1016/S0002-9343(97)00260-X · DOI · Paper page
- Small, 1997, Diagnosis and treatment of Alzheimer disease and related disorders, JAMA, 278, 1363, 10.1001/jama.1997.03550160083043 · DOI · Paper page
- Sugaya, 2000, New anti-inflammatory treatment strategy in Alzheimer's disease, Jpn. J. Pharmacol., 82, 85, 10.1254/jjp.82.85 · DOI
- Tariot, 2000, A 5-month, randomised placebo-controlled trial of galantamine in AD, Am. Acad. Neurol., 54, 2269
- Wagner, 1986, In vitro inhibition of prostaglandin biosynthesis by essential oils and phenolic compounds, Planta Med, 184, 10.1055/s-2007-969117 · DOI
- Xiao, 1998, Effects of estrogen agonists on amphetamine-stimulated dopamine release, Synapse, 2, 379, 10.1002/(SICI)1098-2396(199808)29:4<379::AID-SYN10>3.0.CO;2-M · doi:10.1002/(sici)1098-2396(199808)29:4<379::aid-syn10>3.0.co;2-m
Cited by
Acetylcholinesterase inhibitors from plants
Mukherjee, P. K., Kumar, V., Mal, M., & Houghton, P. J. (2007) · Phytomedicine · doi:10.1016/j.phymed.2007.02.002 · Cited by 809
Self-citationKennedy, D. O., & Wightman, E. L. (2011) · Advances in Nutrition · doi:10.3945/an.110.000117 · Cited by 684
Chemical Composition and Biological Activities of Essential Oils of Curcuma Species
Dosoky, N. S., & Setzer, W. N. (2018) · Nutrients · doi:10.3390/nu10091196 · Cited by 456
Howes, M. R., Perry, N. S. L., & Houghton, P. J. (2003) · Phytotherapy Research · doi:10.1002/ptr.1280 · Cited by 416
Self-citationPerry, N. S. L., Bollen, C., Perry, E. K., & Ballard, C. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00108-4 · Cited by 383
Self-citation
Metadata
- Authors
- Perry, N. S. L., Houghton, P. J., Sampson, J., Theobald, A. E., Hart, S., Lis-Balchin, M., Hoult, J. R. S., Evans, P., Jenner, P., Milligan, S., & Perry, E. K.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-10-01
- Volume
- 53
- Issue
- 10
- Pages
- 1347-1356
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W1990307779
- Cited by
- 159
- References
- 2
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. https://app.cochat.ai/papers/10.1211/0022357011777846
- The paper
- Perry, N. S. L., Houghton, P. J., Sampson, J., Theobald, A. E., Hart, S., Lis-Balchin, M., Hoult, J. R. S., Evans, P., Jenner, P., Milligan, S., & Perry, E. K. (2001). In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. Journal of Pharmacy and Pharmacology. https://doi.org/10.1211/0022357011777846
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.